Centhaquine, a new drug to treat patients who have severe blood or fluid loss, significantly improved outcomes and reduced death rate among shock patients. Centhaquine significantly improved survival ...

Centhaquine is a first-of-its-kind resuscitative agent to treat hypovolemic shock by increasing stroke volume and cardiac output due to an increase in (preload) venous blood return to the heart and a ...

NAPERVILLE, Ill., Nov. 12, 2018 /PRNewswire/ -- Pharmazz, Inc., today announced that data from the Phase 2 clinical study in patients with hypovolemic shock, were presented in the Drug Discovery-Heart ...

(MENAFN- PR Newswire) WILLOWBROOK, Ill., Oct. 28, 2019 /PRNewswire/ -- Pharmazz, Inc., a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat ...

Dr Reddy's and Pharmazz are collaborating to roll out Centhaquine, a revolutionary resuscitative agent for hypovolemic shock in India. The drug aims to improve cardiac output and blood circulation, ...

"I congratulate our team on enrolling the first patient in our Phase 3 trial for VBI-S, our lead asset built on Vivacelle's patented phospholipid nanoparticle technology, which is designed to restore ...

Septic shock affects more than 230,000 U.S. patients each year, but JAMA has published new advances in diagnosing and treating this clinical emergency in hopes of reducing that number. Here are three ...

Shock is a medical emergency. It is a condition wherein the blood flow to the various parts of the body drastically reduces. When the organs and tissues of the body become deprived of the needed ...